NEW YORK (Reuters Health) – Despite its widespread use, there is no conclusive evidence that oxygen therapy benefits patients with acute myocardial infarction (AMI), according to a paper…
NEW YORK (Reuters Health) – The addition of prophylactic phenobarbital to whole-body cooling reduced seizures in newborns with hypoxic-ischemic encephalopathy (HIE) in a small observational study. According to…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate infusions may not help patients with acute aneurysmal subarachnoid hemorrhage, according to a study published in the August issue of…
NEW YORK (Reuters Health) – The new-generation zotarolimus-eluting coronary stent was as safe and effective after 13 months’ follow-up as the everolimus-eluting stent in a study with minimal…
NEW YORK (Reuters Health) – By evaluating risk factors for thromboembolism, physicians can reduce the number of computed tomography (CT) angiograms they order for patients with suspected pulmonary…
NEW YORK (Reuters Health) – Enterally administered probiotic treatment with Lactobacillus rhamnosus GG can cut the rate of ventilator-associated pneumonia (VAP) in high-risk patients, according to pilot study…
NEW YORK (Reuters Health) – Nine times out of 10, patients admitted to a U.S. hospital for acute exacerbation of chronic obstructive pulmonary disease (COPD) are treated initially…
NEW YORK (Reuters Health) – The novel antiarrhythmic agent vernakalant is a safe and effective agent for pharmacologic conversion of recent-onset atrial fibrillation (AF) in hemodynamically stable patients,…
NEW YORK (Reuters Health) – Nonintravenous midazolam (Versed) is better at ending status epilepticus than diazepam (Valium) in children and young adults, and is just as safe, according…
NEW YORK (Reuters Health) – Inhaled anticholinergics may increase the risk of community-acquired pneumonia in asthma patients, results of a Spanish case-control study suggest. The findings, published online…